Stage 4 mesothelioma is the most advanced stage of mesothelioma. In stage 4, tumors have metastasized and spread to distant parts of the body. Treatment for stage 4 mesothelioma focuses on relieving symptoms, and the median survival time is around 14 months.
If you or a loved one have mesotelioma, cáncer de pulmón relacionado con el asbesto o asbestosis, you may be entitled to substantial compensation. Over $30 billion in asbestos trust funds is available right now for those who are dealing with an asbestos disease. FComplete nuestro formulario para obtener un Paquete de Compensación Financiera gratuito. Aprenderá sobre los abogados con experiencia en mesotelioma en su área, cómo recibir su pago en 90 días, cómo presentar una reclamación a los fondos fiduciarios de asbesto y más.


Paquete de compensación financiera GRATUITO
- Información sobre despachos de abogados que recuperarán su INDEMNIZACIÓN MÁS ALTA
- Aprenda cómo cobrar en 90 días
- Solicite su parte de $30 mil millones en fondos fiduciarios
What Is Stage 4 Mesothelioma?
Stage 4 is the final stage of mesothelioma. Once a patient enters the final stage of mesothelioma, the tumor has spread significantly throughout the body. Symptoms are more intense, widespread, and uncomfortable.
The most significant characteristic of stage 4 mesothelioma is metastasis, the distant spread of cancer cells beyond the primary tumor. At this point, physicians usually look for ways to alleviate symptoms and improve a patient’s quality of life.
TNM Designations for Stage 4 Mesothelioma
Doctors stage mesothelioma at the time of diagnosis. The stage designation is important for planning treatment and estimating a patient’s survival time.
Doctors use the TNM (Tumor, Node, Metastasis) system for staging mesothelioma. T describes the primary tumor, N describes the spread of cancer to lymph nodes, and M describes the spread of tumors to distant parts of the body.
There are several possible combinations of TNM designations that describe stage 4 mesothelioma:
- T1 to T4. The T designation can be anywhere from 1 to 4. This means the primary tumor might still be localized in the chest cavity or might have spread within the region.
- N0 to N2. The spread of cancer to the lymph nodes could be minimal or extensive.
- M1. M1 is the most important designation for this stage. It means the cancer is metastatic and has spread to areas of the body distant from the primary tumor.
Stage 4 Peritoneal Mesothelioma
Mesotelioma peritoneal is less common than mesotelioma pleural. It develops in the abdominal cavity rather than the chest. There is no standard staging system for peritoneal mesothelioma. Most doctors use a modified combination of TNM and the Peritoneal Cancer Index.
As with stage 4 pleural mesothelioma, stage 4 peritoneal mesothelioma is characterized by metastasis. There could be any degree of local spread within the abdomen, but the cancer has also spread to distant organs and tissue.
What Are the Metastasis Sites in Stage 4 Mesothelioma?
Every patient is different, and tumors can potentially spread to any location in the body. The most common sites of metastasis for pleural mesothelioma include:
- Lung on the other side of the chest
- Liver
- Kidneys
- Adrenal glands
Less commonly, tumors may spread to bone tissue, the brain, the heart, and the spinal cord.
Typical sites of peritoneal metastasis include:
- Liver
- Lungs
- Kidneys
- Adrenal glands
- Corazón
- Thyroid
- Skin
- Bones
- Brain
Can You Survive Stage 4 Mesothelioma?
Survival times for stage 4 mesothelioma are usually short, around a year or a little more, with good treatment. Mesothelioma at any stage is generally considered incurable, although some patients achieve remission. Remission is very unlikely for stage 4 mesothelioma patients.
The best way to extend life expectancy with stage 4 mesothelioma is with multimodal treatment. This is a combination of treatment types that target the cancer.
Stage 4 Mesothelioma Symptoms
Stage 4 pleural mesothelioma symptoms are often more severe and painful than in previous stages. The early-stage symptoms of coughing, shortness of breath, and chest pains typically worsen. Other symptoms of stage 4 mesothelioma include:
- Tos con sangre
- Difficulty swallowing and eating
- Sudores nocturnos
- Fiebre
- Unintentional weight loss
- pérdida de masa muscular
- Fatiga
- Malaise
Typical symptoms of stage 4 peritoneal mesothelioma include:
- Dolor e hinchazón abdominal
- Fluid buildup in the abdomen
- Constipation
- Diarrhea
- Intestinal blockage
- Unintentional weight loss
- pérdida de masa muscular
- Fatigue and malaise
- Fiebre
- Sudores nocturnos
Stage 4 mesothelioma patients also experience symptoms related to sites of metastasis. For example, if tumors have spread to the bone, it can cause significant pain. Tumors in the brain can cause headaches, dizziness, and seizures.
How Is Stage Mesothelioma 4 Treated?
Patients in stage 4 have limited tratamiento options. The main focus of treatment at this late stage is palliation to make the patient feel better. Treatment can also extend life expectancy.
Surgery and Palliative Treatments for Stage 4 Mesothelioma
Surgery to remove significant cancerous tissue and to extend life expectancy is not always an option for stage 4 mesothelioma patients. Often, the cancer is too widespread for this to be a good treatment option.
Some patients with stage 4 mesothelioma might qualify for and choose a curative type of surgery, typically pleurectomy/decortication. This procedure removes an extensive amount of tissue from the chest cavity.
According to one study, this surgery, combined with photodynamic therapy and chemotherapy, extended life expectancy for several late-stage mesothelioma patients. Even for patients with extensive cancer spread, this multimodal treatment strategy prolonged life to between one and three years.
Palliative surgical procedures are also available to patients not eligible for or who do not want to undergo radical surgeries:
- toracocentesis is a procedure that drains uncomfortable fluid from the chest cavity.
- Paracentesis drains fluid from the abdominal cavity in patients with peritoneal mesothelioma or abdominal metastases.
- Pericardiocentesis removes fluid from the area around the heart.
- Pleurodesis is a procedure that seals the two layers of the pleura to prevent fluid from building up again.
Some patients benefit from surgery to remove some metastatic tumors that cause significant symptoms. For instance, a tumor pressing on nerves can cause a lot of pain. Surgery to remove it or reduce its size can be helpful.
Chemotherapy and Radiation
Quimioterapia helps shrink the tumors to provide symptom relief. Radiation therapy can do the same and, for some patients, causes fewer side effects. In some instances, chemotherapy and radiation are combined, depending on the patient’s overall health and ability to sustain both treatments.
The standard chemotherapy combination for mesothelioma is pemetrexed with cisplatin. Some patients might also receive bevacizumab, a targeted drug, which might help extend survival time.
Additional Treatment Options for Stage 4 Mesothelioma
Surgery, chemotherapy, and radiation therapy are the standard treatments for mesothelioma, but there are other options and emerging treatments:
- Immunotherapy. Immunotherapy is becoming more common. It is a treatment that uses medications to harness the patient’s immune system to kill cancer cells. Results from a recent clinical trial found that treatment with two immunotherapy drugs extended survival times for patients who were ineligible for surgery. This was compared to chemotherapy.
- Cryotherapy. Cryotherapy is an emerging treatment that uses cold temperatures to kill cancer cells.
- Tumor Treating Fields. This is another emerging treatment that might be available to some patients. It uses electric fields outside the body to target and kill cancer cells.
- Clinical trials. A clinical trial might also be an option for a stage 4 patient. Clinical trials test emerging therapies and new medication combinations with human subjects. It can be a good way to access treatments not yet widely available.
Stage 4 mesothelioma patients have more treatment options than they might realize. It’s essential that you talk to your medical team about these options and discuss which might be best for your treatment goals.
What Is the Prognosis for Stage 4 Mesothelioma?
In general, the pronóstico for stage 4 mesothelioma is not positive. Because the cancer is so widespread, eliminating all tumors is unlikely. Treatment is still important. It provides symptom relief and extends survival time.
What Is the Survival Time for Stage 4 Mesothelioma?
The median survival time for stage 4 mesothelioma patients is 14.9 months. This statistic comes from a large group of patients who underwent treatment. The survival time is much less, about six months, for patients who do not receive treatment.
What Factors Influence Stage 4 Survival Time?
Estimates of survival time or life expectancy are highly individualized. The statistics that include many patients are important, but individual factors also play a major role in prognosis:
- Women have better survival rates than men
- Younger patients in better overall health have better survival rates
- Patients with the epithelioid cell type have better outcomes than those with the rarer and more aggressive sarcomatoid cell type.
- Peritoneal mesothelioma patients generally have a better prognosis than pleural mesothelioma patients.
How to Improve Your Stage 4 Mesothelioma Prognosis
A diagnosis of stage 4 mesothelioma might seem overwhelming, but it is not hopeless. The best thing you can do to improve your outlook is to get treatment. You’ll get the best outcome from working with mesothelioma specialists, choosing the most aggressive treatments possible, and starting treatment right away.
Living With Stage 4 Mesothelioma
Living with advanced, terminal cancer presents many challenges. Patients with end-stage cancer cope with physical discomfort, treatments, and mental health issues. They have to make important practical decisions and often worry about loved ones they will leave behind.
If you are facing a stage 4 mesothelioma diagnosis, take these steps to cope better:
- Set Treatment Goals. Patients too often let their doctors take over treatment, but you have control over what happens. Talk to your doctors about what you want to get out of treatment and take charge of the plan.
- Choose Palliative Care. Palliative treatments are so important for helping you feel more comfortable and improving your quality of life for the time you have left.
- Choose Mental Health Care. Mental health is too often neglected but is an important aspect of living with cancer. Talk to your medical team about working with a trained mental health specialist with cancer experience.
- Rely on Your Support Network. Let your friends and family help you during this difficult time. They can support you with practical help and by being there to listen. Cancer support groups can also provide comfort.
- Make End-of-Life Plans. Let your closest loved ones help you make important end-of-life decisions. These include legal, financial, and healthcare decisions. Make your preferences known now, so your loved ones can implement them later.
Obtener ayuda legal
Recuerde, si le han diagnosticado mesotelioma, cáncer de pulmón relacionado con el asbesto o asbestosis, regardless of what stage, there is a good chance you qualify for significant compensation. No olvides rellenar nuestro formulario para obtener nuestro regalo gratis. Paquete de compensación financiera, lleno de información sobre los abogados con experiencia en asbesto y mesotelioma en tu zona. If you have questions or need assistance, contact us toll-free at 800-793-4540.

Pablo Danziger
Revisor y editorPaul Danziger creció en Houston, Texas, y se licenció en Derecho en la Facultad de Derecho de la Universidad Northwestern en Chicago. Durante más de 25 años, se ha dedicado a representar a víctimas de mesotelioma y a otras personas afectadas por la exposición al asbesto. Paul y su bufete han representado a miles de personas diagnosticadas con mesotelioma, asbestosis y cáncer de pulmón, obteniendo indemnizaciones significativas para los clientes lesionados. Cada cliente es fundamental para Paul y atenderá todas las llamadas de quienes deseen hablar con él. Paul y su bufete se encargan de casos de mesotelioma en todo Estados Unidos.
Conéctese con el abogado especializado en mesotelioma Paul Danziger
Referencias
- Moore, A.J., Parker, R.J., and Wiggins, J. (2008, December 19). Malignant Mesothelioma. Orphanet J. Rare Dis. 3, 34. doi: 10.1186/1750-1172-3-34.
Recuperado de: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652430/?tool=pmcentrez - National Cancer Institue. (2021, May 21). Malignant Mesothelioma Treatment (Adult) (PDQ®)–Patient Version.
Recuperado de: http://www.cancer.gov/cancertopics/pdq/treatment/malignantmesothelioma/patient/page2 - American Cancer Society. (2018, November 16). Survival Statistics for Mesothelioma.
Recuperado de: https://www.cancer.org/cancer/malignant-mesothelioma/detection-diagnosis-staging/survival-statistics.html - Collins, D.C., Constantinidou, A., Sundar, R., Chenard-Poirier, M., Yap, T.A., Banerji, U., De Bono, J.S., Lopez, J., S., and Tunariu, N. (2017, May 20). Patterns of Metastases in Malignant Pleural Mesothelioma in the Modern Era: Redefining the Spread of an Old Disease. J. Clin. Oncol. 35(15 Supp), DOI: 10.1200/JCO.2017.35.15_suppl.8556.
Recuperado de: https://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.8556 - Bridda, A., Padoan, I., Mencarelli, R., and Frego, M. (2007). Peritoneal Mesothelioma: A Review. MedGenMed. 9(2), 32.
Recuperado de: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994863/ - Friedberg, J.S., Simone, II, C.B., Culligan, M.J., Barsky, A.R., Doucette, A., McNulty, S., Hahn, S.M., Alley, E., Sterman, D.H., Glatstein,E., and Cengel, K.A. (2017, March). Extended Pleurectomy/Decortication-Based Treatment for Advanced Stage, Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years. Ann. Thorac. Surg. 103(3), 912-19.
Recuperado de: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568093/ - Nowak, AK, Chansky, K., Rice, DC, Pass, HI, Kindler, HL, Shemanski, L., Bille, A., Rintoul, RC, Batirel, HF, Thomas, CF, Friedberg, J., Cedres, S., de Perrot, M. y Rusch, VW (diciembre de 2016). Proyecto de Estadificación del Mesotelioma de la IASLC: Propuestas de Revisión de los Descriptores T en la Próxima Octava Edición de la Clasificación TNM para el Mesotelioma Pleural. J. Thor. Onc. 11(12), 2089-99.
Recuperado de: https://www.jto.org/article/S1556-0864(16)31070-X/fulltext - Baas, P., Scherpereel, A., Nowak, A.K., Fujimoto, N., Peters, S., Tsao, A.S., Mansfield, A.S., Popat, S., Jahan, T., Antonia, S., Oulkhouir, Y., Bautista, Y., Cornelissen, R., Greillier, L., Grossi, F., Kowalski, D., Rodriquez-Cid, J., Aanur, P., Oukessou, A., Baudelet, C., and Zalcman, G. (2021, January 30). First-Line Nivolumab Plus Ipilimumab in Unresectable Malignant Pleural Mesothelioma (CheckMate743): A Multicentre, Randomised, Open-Label, Phase 3 Trial. Lancet. 397(10272), 375-86.
Recuperado de: https://pubmed.ncbi.nlm.nih.gov/33485464/